Skip to main content

Advertisement

SpringerLink
Log in

I-123 MIBG cardiac scintigraphy and autonomic test evaluation in multiple sclerosis patients

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Autonomic symptoms are common in multiple sclerosis (MS) patients and may cause significant disability. The purpose of this study was to evaluate direct cardiac sympathetic denervation in MS patients with I-123 MIBG cardiac scintigraphy compared with other parasympathetic electrophysiological examinations of autonomic dysfunction. Ten patients with MS and 7 age- and sex-matched control subjects were prospectively evaluated. The neurological deficit and disability stages of the patients were rated according to the Kurtzke Expanded Disability Status Scale (EDSS). Autonomic tests included the R-R interval, Valsalva ratio and standup test. All patients and control subjects had planar and SPECT cardiac scintigraphy with I-123 MIBG injection. Seven MS patients had relapsing-remitting (R-R) type and three had secondary progressive type (SP). A pathological MIBG cardiac washout rate was found in 3/10 MS patients, all of them with SP-MS. The other seven had normal washout rates. No correlation was found between the scan and the individual parasympathetic autonomic test results. I-123 MIBG myocardial scintigraphy may detect direct disturbances of the sympathetic cardiac function in patients with MS in addition to parasympathetic dysfunction tests and can be an important additional means of assessing autonomic pathways. Determination in MS of the co-existence of autonomic dysfunction, especially the cardiac sympathetic involvement in the SP type, may aid in evaluation of disease severity and cardiac function follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beer M, Sandstede J, Weilbach F, Spindler M, Buchner S, Krug A, Kostler H, Pabst T, Kenn W, Landschutz W, Von Kielin M (2001) Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study. Rofo 173:399–404

    PubMed  CAS  Google Scholar 

  2. Braune S, Reinhardt M, Bathmann J, Krause T, Lethmann M, Lucking CH (1998) Impaired cardiac uptake of meta-[123I] iodobenzylguanidine in Parkinson’s disease with autonomic failure. Acta Neurol Scand 97:307–314

    PubMed  CAS  Google Scholar 

  3. Choi JY, Lee KH, Hong KP, Kim BT, Sev JD, Lee WR, Lee SH (2001) Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity. J Nucl Cardiol 8:4–9

    Article  PubMed  CAS  Google Scholar 

  4. de-Seze J, Stojkovic T, Gauvrit JY, Devos D, Ayachi M, Cassim F, Faint Michel T, Pruvo JP, Gviev JD, Vermersch P (2001) Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates. J Neurol 248:297–303

    Article  PubMed  CAS  Google Scholar 

  5. Fowler C, Henry M (1996) Gastrointestinal dysfunction in multiple sclerosis. Semin Neurol 16:277–279

    Article  PubMed  CAS  Google Scholar 

  6. Gunal DI, Afsar N, Tahniday T, Aktan S (2002) Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters. Eur Neurol 48(1):1–5

    Article  PubMed  Google Scholar 

  7. Haensch CA, Jong J (2006) Autonomic dysfunction in multiple sclerosis. J Neurol 253(Suppl I):I3–I9

    Article  PubMed  Google Scholar 

  8. Hattori N, Tamaki N, Hayashi T, Masuda I, Kudoh T, Tateno M, Tadamuna E, Yonekura Y, Nakao K, Konishi J (1996) Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 37:1985–1990

    PubMed  CAS  Google Scholar 

  9. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kuldarni P, Vgolini V, Akers MS, Hansen C, Buja LM, et al. (1988) Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 78:1192–1199

    PubMed  CAS  Google Scholar 

  10. Kashihara K, Yamamoto M (2006) Myocardial (123)-MIBG scintigraphy in patients with PSP, CBD and MSA. J Neurol 253(Suppl 3):11B5–11B40

    Google Scholar 

  11. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, Beierwalter WH (1981) Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 22:129–132

    PubMed  CAS  Google Scholar 

  12. Kodounis A, Stamboulis E, Constantinidis TS, Liolios A (2005) Measurement of autonomic dysregulation in multiple sclerosis. Acta Neurol Scand 112:403–408

    Article  PubMed  CAS  Google Scholar 

  13. Kurtzke JE (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452

    PubMed  CAS  Google Scholar 

  14. Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV (2001) Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 7(5):327–334

    PubMed  CAS  Google Scholar 

  15. McDougall AJ, McLoad JG (2003) Autonomic nervous system function in multiple sclerosis. J Neurol Sci 215:79–85

    Article  PubMed  CAS  Google Scholar 

  16. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourgvignon MH, Benevenuti C, Duval AM, Agostini D, et al. (1992) Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33:471–477

    PubMed  CAS  Google Scholar 

  17. Morimoto S, Terada K, Keira N, Satoda M, Inoue K, Tatsukawa H, Katoh S, Ida K, Sugihara H, Takeda K, Nakajawa M (1996) Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous system dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging. Eur J Nucl Med 23:756–761

    Article  PubMed  CAS  Google Scholar 

  18. Nagamachi S, Jinnouchi S, Kurose T, Ohnishi T, Flores LG 2nd, Nakahara H, Futami S, Tamun S, Matsukuna S (1998) I-123 MIBG myocardial scintigraphy in diabetic patients: relationship with 201TI uptake and cardiac autonomic function. Ann Nucl Med 12:323–331

    Article  PubMed  CAS  Google Scholar 

  19. Poser CM, Paty DW, Scheinberg C (1983) New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol 13:227–231

    Article  PubMed  CAS  Google Scholar 

  20. Raum W, Laks M, Garner D, Swerdloff R (1983) Beta-adrenergic receptor and cyclic AMP alterations in the canine ventricular septum during long-term norepinephrine infusion: implications for hypertrophic cardiomyopathy. Circulation 68:693–699

    PubMed  CAS  Google Scholar 

  21. Saari A, Tolonen U, Paakko E, Svominen K, Pyhtinen J, Sotaniemi K, Myllyla V (2004) Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clin Neurophysiol 115:1473–1478

    Article  PubMed  CAS  Google Scholar 

  22. Scofer J, Spielmann R, Schuchert A, Weber K, Schluter M (1988) Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 12:1252–1258

    Article  Google Scholar 

  23. Simpson P (1985) Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of heating through an alpha 1- and beta 1- adrenergic receptor interaction: evidence for independent regulation of growth and beating. Circ Res 56:884–894

    PubMed  CAS  Google Scholar 

  24. Stalberg EV, Nogues MA (1989) Autonomic analysis of heart rate variation: I Method and reference values in healthy controls. Muscle and Nerve 12:993–1000

    Article  PubMed  CAS  Google Scholar 

  25. Valette H, Srota A (1998) Nuclear techniques in the assessment of myocardial innervation. In:Murry IPC (ed) Nuclear medicine in clinical diagnosis and treatment. Churchill Livingstone, pp 1525–1529

Download references

Author information

Authors and Affiliations

  1. Dept. of Nuclear Medicine, E. Wolfson Medical Center, Holon, 58100, Israel

    M. Lorberboym M.D., Head & G. Nikolov M.D.

  2. Dept. of Neurology, E. Wolfson Medical Center, Holon, 58100, Israel

    Y. Lampl M.D., Head, M. Sadeh M.D. & R. Gilad M.D.

Authors
  1. M. Lorberboym M.D., Head
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Lampl M.D., Head
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Nikolov M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Sadeh M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Gilad M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

All departments are affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Israel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lorberboym, M., Lampl, Y., Nikolov, G. et al. I-123 MIBG cardiac scintigraphy and autonomic test evaluation in multiple sclerosis patients. J Neurol 255, 211–216 (2008). https://doi.org/10.1007/s00415-008-0652-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0652-x

Key words

Search

Navigation